Peter G. Falkai
Expertise in
8
conditions

Peter G. Falkai

Von Siebold Str. 5, 
Goettingen, NI, DE 
Expertise in
8
conditions
Von Siebold Str. 5, 
Goettingen, NI, DE 

Overview

Peter Falkai practices practicing medicine in Goettingen, Germany.

Mr. Falkai is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Schizophrenia, Bipolar Disorder (BPD), Schizoaffective Disorder, and Major Depression.

He is actively involved in clinical research, co-authoring 712 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Von Siebold Str. 5, Goettingen, NI 37075, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Enhancing Recovery in Early Schizophrenia - a Multi-center, Two-arm, Double-blind, Randomized Phase II Trial Investigating Cannabidiol vs. Placebo as an add-on to an Individualized Antipsychotic Treatment
Enhancing Recovery in Early Schizophrenia - a Multi-center, Two-arm, Double-blind, Randomized Phase II Trial Investigating Cannabidiol vs. Placebo as an add-on to an Individualized Antipsychotic Treatment
Enrollment Status: Active_not_recruiting
Publish Date: February 03, 2026
Intervention Type: Drug
Study Drug: Cannabidiol as Add-On
Study Phase: Phase 2
A Four-week, Multicentre, Double-blinded, Randomised, Active- and Placebo- Controlled, Parallel-group Trial Investigating Efficacy and Safety of Cannabidiol in Acute, Early-stage Schizophrenic Patients
A Four-week, Multicentre, Double-blinded, Randomised, Active- and Placebo- Controlled, Parallel-group Trial Investigating Efficacy and Safety of Cannabidiol in Acute, Early-stage Schizophrenic Patients
Enrollment Status: Terminated
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Cannabidiol, Olanzapine
Study Phase: Phase 2
View 1 Less Clinical Trial

711 Total Publications

Frequency and Correlates of Inaccurate Psychiatric Diagnoses in 401 Adults Hospitalized for Major Depressive Disorder: A Comparison of Clinical vs. Research Interview-Based Diagnoses.
Frequency and Correlates of Inaccurate Psychiatric Diagnoses in 401 Adults Hospitalized for Major Depressive Disorder: A Comparison of Clinical vs. Research Interview-Based Diagnoses.
Journal: CNS spectrums
Published: June 09, 2026

Frequently Asked Questions about Peter G. Falkai

Is Peter G. Falkai a top-rated expert for Schizophrenia?

MediFind is an objective health platform that identifies experts based on real-world data. Peter G. Falkai is classified as an Elite expert for Schizophrenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter G. Falkai participate in research or clinical trials?

Yes. Peter G. Falkai has published 711 articles and abstracts on conditions like Schizophrenia. You can view a list of Peter G. Falkai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Falkai's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile